IGM Biosciences Inc Sustainability Reports
A biotechnology company engaged in developing engineered IgM antibodies for the treatment of autoimmune diseases, inflammation, and cancer.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 5493008XCQES2N0VY969
FIGI: BBG00PNR1BV9
4 reports from 2020 to 2023
